Velsera

Velsera is a precision medicine technology company that provides genomics software and expert services. Its products include the Seven Bridges Platform (a trusted research environment for bioinformatics analysis and pipeline development), GRAF (reference genome alignment and variant calling), ARIA (data harmonization and secure sharing), Clinical Genomics Workspace (tertiary analysis and reporting for NGS testing), and a clinical variant interpretation knowledgebase.

Its customers are biotech and pharma companies, clinical diagnostic labs, NGS assay and equipment manufacturers, and non-profit and government research organizations. The website describes a model that combines software with expert services in bioinformatics, clinical, regulatory and data harmonization areas; it does not describe pricing or revenue details. Testimonials cite Weill Cornell Medicine and Dartmouth-Hitchcock Health.

The website states a track record of over 10 years and describes the company as an established scale-up. It cites 80+ active clinical NGS lab customers, 18,000+ researchers using the Seven Bridges Platform and 50+ data partners. Its CEO joined in February 2026 and its President and Chief Business Officer in May 2026. Open roles listed on the careers page are in the US, UK, Sweden and India, including engineering, product, data, compliance and sales positions.

Product: Seven Bridges Platform, GRAF, ARIA, Clinical Genomics Workspace and Knowledgebase for genomics analysis, data harmonization and NGS reporting, plus expert services.